^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

dHER2+AS15

i
Other names: dHER2 ASCI, HER2-antigen specific cancer immunotherapeutic, Immunotherapeutic SB719125, dHER2+AS15, dHER2+AS15 ASCI, HER2 ASCI
Associations
News
Company:
GSK
Drug class:
HER2 inhibitor
Related drugs:
Associations
News